Carsten Boess - Net Worth and Insider Trading

Carsten Boess Net Worth

The estimated net worth of Carsten Boess is at least $0 dollars as of 2024-11-13. Carsten Boess is the Former Chief Financial Officer of Alexion Pharmaceuticals Inc and owns about 0 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $0. Carsten Boess is also the Vice President, International of Insulet Corp and owns about 0 shares of Insulet Corp (PODD) stock worth over $0. Details can be seen in Carsten Boess's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carsten Boess has not made any transactions after 2011-04-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Carsten Boess

To

Carsten Boess Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carsten Boess owns 7 companies in total, including Health Sciences Acquisitions Corp 2 (HSAQ) , Rocket Pharmaceuticals Inc (RCKT) , and Avidity Biosciences Inc (RNA) among others .

Click here to see the complete history of Carsten Boess’s form 4 insider trades.

Insider Ownership Summary of Carsten Boess

Ticker Comapny Transaction Date Type of Owner
HSAQ Health Sciences Acquisitions Corp 2 2020-08-03 director
RCKT Rocket Pharmaceuticals Inc 2016-01-11 director
RNA Avidity Biosciences Inc 2020-06-11 director
LIMIT LIMIT 2018-05-23 10 percent owner
LIMIT LIMIT 2011-04-25 Chief Financial Officer
LIMIT LIMIT 2005-06-27 other: Former Chief Financial Officer
LIMIT LIMIT 2020-08-03 director

Carsten Boess Latest Holdings Summary

Carsten Boess currently owns a total of 2 stocks. Among these stocks, Carsten Boess owns 0 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 27, 2005, with a value of $0 . Carsten Boess also owns 0 shares of Insulet Corp (PODD) as of April 25, 2011, with a value of $0 .

Latest Holdings of Carsten Boess

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2005-06-27 0 182.50 0
PODD Insulet Corp 2011-04-25 0 275.10 0

Holding Weightings of Carsten Boess


Carsten Boess Form 4 Trading Tracker

According to the SEC Form 4 filings, Carsten Boess has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 45,000 shares on June 27, 2005, which brought Carsten Boess around $263,138.

According to the SEC Form 4 filings, Carsten Boess has made a total of 0 transactions in Insulet Corp (PODD) over the past 5 years. The most-recent trade in Insulet Corp is the sale of 41,296 shares on April 25, 2011, which brought Carsten Boess around $889,516.

Insider Trading History of Carsten Boess

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carsten Boess Trading Performance

GuruFocus tracks the stock performance after each of Carsten Boess's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carsten Boess is 85.87%. GuruFocus also compares Carsten Boess's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carsten Boess within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Carsten Boess's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Carsten Boess

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 80 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 82.82 LIMIT LIMIT LIMIT LIMIT LIMIT

Carsten Boess Ownership Network

Ownership Network List of Carsten Boess

No Data

Ownership Network Relation of Carsten Boess

Insider Network Chart

Carsten Boess Owned Company Details

What does Health Sciences Acquisitions Corp 2 do?

Who are the key executives at Health Sciences Acquisitions Corp 2?

Carsten Boess is the director of Health Sciences Acquisitions Corp 2. Other key executives at Health Sciences Acquisitions Corp 2 include director & See Remarks David P Hochman , Chief Financial Officer Michael Kaswan , and director & See Remarks Darren Sherman .

Health Sciences Acquisitions Corp 2 (HSAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Health Sciences Acquisitions Corp 2 (HSAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Health Sciences Acquisitions Corp 2 (HSAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Health Sciences Acquisitions Corp 2 (HSAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Health Sciences Acquisitions Corp 2 Insider Transactions

No Available Data

Carsten Boess Mailing Address

Above is the net worth, insider trading, and ownership report for Carsten Boess. You might contact Carsten Boess via mailing address: C/o Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton D0 Hm11.